Definium Therapeutics, Inc. (DFTX) — Operating Income

Annual figures by fiscal year, from SEC filings.

2020: -$33.03M2021: -$93.85M2022: -$66.33M2023: -$93.87M2024: -$103.92M2025: -$166.31M-$166.31M
2020Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$166.31M-60.0%
2024-$103.92M-10.7%
2023-$93.87M-41.5%
2022-$66.33M+29.3%
2021-$93.85M-184.1%
2020-$33.03M